Spark Therapeutics

News

Novartis snaps up ex-US partnership with Spark on gene thera...

I was at Novartis headquarters in Basel yesterday for the company’s Q4 results, and my burning question was – did the company have any designs on entering the viral vector-based gene therap

News

Spark divides opinion with $850,000 gene therapy

Spark offers efficacy-based rebates and deferred payments to mitigate costs

News

FDA makes history, approving Spark's eye gene therapy

Christmas has come a few days early for Spark Therapeutics after the FDA approved its ground-breaking gene therapy for a rare eye disease.

News

Spark and Pfizer’s gene therapy wows in haemophilia B

Gene therapy company Spark Therapeutics has published data showing its one-time treatment can almost entirely eliminate bleeds in patients with haemophilia B.

Views & Analysis